Potentially game-changing schizophrenia drug enters Phase I trials
Drug Discovery World
DECEMBER 7, 2023
Our work with Neumora is the very definition of translational research and the work we aim to do every day, which is applying innovation and discovery to help address the world’s most complex challenges.” Overactive transmission of dopamine is connected to the positive, negative and cognitive symptoms of schizophrenia.
Let's personalize your content